Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences Corporation is trading near record highs as Wall Street shifts to “Hold,” merger-arb funds move in and shareholder lawyers start circling Abbott’s $21 billion bid.

Mergers and Acquisitions · NASDAQ:EXAS · NYSE:ABT
Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories shook the healthcare and medtech markets today, November 20, 2025, by announcing a definitive agreement to acquire cancer diagnostics specialist Exact Sciences Corporation in an all‑cash transaction valuing the target at about $21 billion in equity and roughly $23 billion including debt. Reuters+2PR Newswire+2
20 November 2025
··

Stock Market Today 20.10.2025

ENDEDLive coverage has endedEnded: October 22, 2025, 6:02 AM EDT Powell Hints End of Quantitative Tightening Could Boost Stocks, But Risks Linger October 21, 2025, 5:56 AM EDT. When Powell speaks, markets listen. At a recent conference, he signaled the Fed could soon pause its balance-sheet runoff, effectively winding down quantitative tightening. A close to QT would not automatically unleash quantitative easing, but it could shift monetary policy toward easier conditions and potentially support the stock market. Yet the picture is nuanced: ending QT doesn't guarantee a rally, and it could reflect a softer economy or cooling earnings. The Fed's
20 October 2025
···
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott’s stock has been trading in a tight range around $128–$133 in mid-October 2025. On Oct 15, the price was about $128 – down 3.5% intradayreuters.com. Over the past few trading days ABT fell from $131.38 and $133.27 to $128.77stockanalysis.com. In context, ABT’s YTD gain is roughly 18%, outpacing the broad market. The stock’s forward P/E is about 24–25tradingview.com, suggesting analysts see modest growth ahead.
15 October 2025
··
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

The months of June and July 2025 have been packed with developments in wearable devices and health-sensing technology. This report compiles global news from this period, including major product launches, breakthroughs in wearable health sensors, key regulatory approvals, emerging market trends and forecasts, recent clinical research findings, and notable expert commentary. The focus is on authoritative sources such as company press releases, medical journals, regulatory announcements, and reputable news outlets. Each section below is structured to provide a clear overview of the latest happenings, with sources cited for verification.
7 July 2025
···
1 2 3
Follow on Google News
Add as preferred source Open in Google News

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong Buy

NVIDIA

94/100
#2 Strong Buy

Meta Platforms

89/100
#3 Buy

Alphabet

87/100
#4 Buy

Amazon

84/100
#5 Selective Buy

Microsoft

82/100
View full portfolio
Editorial model selection. Not personalised advice.